Cardinal Health Inc (CAH)

Currency in USD
149.51
+0.27(+0.18%)
Closed·
149.50-0.01(-0.01%)
·
CAH Scorecard
Full Analysis
Management has been aggressively buying back shares
CAH is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
148.28151.00
52 wk Range
106.54168.44
Key Statistics
Prev. Close
149.24
Open
148.92
Day's Range
148.28-151
52 wk Range
106.54-168.44
Volume
3.29M
Average Volume (3m)
2.29M
1-Year Change
34.65%
Book Value / Share
-11.65
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CAH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
180.46
Upside
+20.70%
Members' Sentiments
Bearish
Bullish
ProTips
5 analysts have revised their earnings upwards for the upcoming period

Cardinal Health Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Cardinal Health Inc Company Profile

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Employees
55392

Cardinal Health Inc SWOT Analysis


Financial Triumph
Cardinal Health surpasses Q1 expectations, raising FY25 EPS guidance amid strong pharmaceutical and specialty segment performance
Strategic Expansion
Acquisition of Integrated Oncology Network for $1.115B signals shift to offensive growth strategy in community oncology market
Segment Dynamics
Explore the contrasting performances of Cardinal Health's divisions, with pharmaceutical success offsetting challenges in medical products
Market Positioning
Analysts set price targets ranging from $107 to $133, reflecting confidence in Cardinal Health's growth potential and strategic direction
Read full SWOT analysis

Cardinal Health Inc Earnings Call Summary for Q4/2025

  • Q4 2025 EPS beat at $2.08, revenue missed at $60.2B; stock dropped 11.58% pre-market
  • Operating earnings up 19% to $719M; FY2026 EPS guidance raised to $9.30-$9.50, projecting 13-15% growth
  • Strategic acquisitions like Solaris Health and new product launches highlight innovation focus
  • Pharmaceutical segment revenue growth forecast at 11-13%; other growth businesses at 26-28%
  • CEO emphasizes unique market position; CFO confident in strong operating earnings growth for coming year
Last Updated: 12/08/2025, 14:40
Read Full Transcript

Compare CAH to Peers and Sector

Metrics to compare
CAH
Peers
Sector
Relationship
P/E Ratio
22.9x−1.2x−0.6x
PEG Ratio
0.260.000.00
Price/Book
−12.8x0.7x2.6x
Price / LTM Sales
0.2x0.8x3.3x
Upside (Analyst Target)
22.4%40.7%39.1%
Fair Value Upside
Unlock22.4%5.4%Unlock

Analyst Ratings

11 Buy
5 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 180.46
(+20.70% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.48%
Dividend Yield
1.37%
Industry Median 2.88%
Annualised payout
2.04
Paid quarterly
5-Years Growth
+1.10%
Growth Streak

Earnings

Latest Release
Aug 12, 2025
EPS / Forecast
2.08 / 2.03
Revenue / Forecast
60.20B / 60.92B
EPS Revisions
Last 90 days

CAH Income Statement

People Also Watch

36.87
YOU
+0.88%
302.29
UNH
-0.52%
188.73
IQV
-0.04%
137.65
FI
-0.24%
310.41
ELV
+0.19%

FAQ

What Stock Exchange Does Cardinal Health Trade On?

Cardinal Health is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Cardinal Health?

The stock symbol for Cardinal Health is "CAH."

What Is the Cardinal Health Market Cap?

As of today, Cardinal Health market cap is 35.70B.

What Is Cardinal Health's Earnings Per Share (TTM)?

The Cardinal Health EPS (TTM) is 6.48.

When Is the Next Cardinal Health Earnings Date?

Cardinal Health will release its next earnings report on 30 Oct 2025.

From a Technical Analysis Perspective, Is CAH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Cardinal Health Stock Split?

Cardinal Health has split 11 times.

How Many Employees Does Cardinal Health Have?

Cardinal Health has 55392 employees.

What is the current trading status of Cardinal Health (CAH)?

As of 29 Aug 2025, Cardinal Health (CAH) is trading at a price of 149.51, with a previous close of 149.24. The stock has fluctuated within a day range of 148.28 to 151.00, while its 52-week range spans from 106.54 to 168.44.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.